跳至主要内容
临床试验/CTRI/2020/05/025335
CTRI/2020/05/025335已完成3 期

A Pilot Study To Assess The Efficacy Of AYUSH - 64 In COVID - 19 Cases

Central Council for Research in Ayurvedic Sciences CCRAS0 个研究点目标入组 37 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
37

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Mild to moderate cases registered in CHC CBPACS above 18 years of age, with COVID 2019 (Confirmed by RT-PCR)
  • Participants who can take medicines orally
  • Patients willing to provide signed informed consent

排除标准

  • Cases of severe vomiting which would make oral administration of medicine difficult.
  • Cases of respiratory failure and requiring mechanical ventilation.
  • Alanine Transaminase (ALT) or Aspartate Transaminase (AST) > 2 times the upper limit of normal.
  • Patients with COVID 19 in critical condition or ARDS or NIAD 8 â??point ordinal score 2 Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
  • Pregnant or lactating women
  • Any other condition, which as per the investigator would jeopardize the outcome of the trial.

研究者

发起方
Central Council for Research in Ayurvedic Sciences CCRAS

相似试验